• Core Laboratories Inc CLB.N reported quarterly adjusted earnings of 14 cents​​ per share for the quarter ended March 31, lower than the same quarter last year, when the company reported EPS of 19 cents. The mean expectation of five analysts for the quarter was for earnings of 15 cents per share. Wall Street expected results to range from 13 cents to 17 cents per share.

• Revenue fell 4.7% to $123.59 million from a year ago; analysts expected $124.76 million.

• Core Laboratories Inc's reported EPS for the quarter was breakeven results​.

• The company reported a quarterly loss of $154 thousand.

• Core Laboratories Inc shares had fallen by 17.0% this quarter and lost 28.1% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 34.1% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy," 3 "hold" and 1 "sell" or "strong sell." The average consensus recommendation for the business support services peer group is also "hold"

• Wall Street's median 12-month price target for Core Laboratories Inc is $16.00

This summary was machine generated from LSEG data April 23 at 10:37 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)